| Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma | skin, |
| identified a series of differentially expressed miRNAs that could be useful as diagnostic or prognostic markers for melanoma and have shown that three miRNAs (namely miR-200c, miR-205 and miR-211) act as tumour suppressors | skin, |
| our results provide evidence that miR-211 is involved in the development of GBM. Furthermore, we demonstrated that miR-211 functions as a tumor suppressor in GBM, at least, partly through repression of the HMGA2/AKT/beta-catenin axis. | GBM, |
| Findings collectively demonstrate a tumour suppressor role of miR-211-5p in triple negative breast cancer progression by targeting SETBP1. | breast, |
| miR211 may act as a tumor suppressor in cervical cancer by directly targeting ZEB1. | cervical, |
| Tumor suppressor miR-211-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma | kidney, |
| Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma | liver, |
| MiR-211 is a tumor suppressor that controls expression of Cyclin D1 and CDK6. | None |
| miR-211 may function as an oncogenic miRNA in non-small cell lung cancer, partly by regulating SRCIN1 | lung, |